Tag: raw materials

Understanding the Impact of Particle Size Variability during Supplier Changes on Drug Performance The introduction of new suppliers or raw materials is a common challenge in pharmaceutical manufacturing. A significant…

Investigation of API Assay Variability Surpassing Trend Limits in Stability Studies The pharmaceutical industry faces constant scrutiny regarding the integrity of its data and the quality of its Active Pharmaceutical…

Addressing API Stability Failures during Incoming Testing to Prevent Batch Rejection and Recalls An API stability failure during incoming testing can lead to significant quality issues and operational disruptions in…

Investigating Impurity Profile Drift: An Essential Guide for Regulatory Compliance In pharmaceutical manufacturing, the integrity of raw materials and APIs is paramount. An impurity profile drift detected during a deviation…

Assessing API Assay Variability That Exceeds Trend Limits During Incoming Testing In the realm of pharmaceutical manufacturing, variabilities in active pharmaceutical ingredients (APIs) can critically impact product quality and compliance…

Addressing Impurity Profile Drift in Pharmaceutical Manufacturing Investigations Impurity profile drift can lead to significant quality control issues in pharmaceutical manufacturing, specifically during the production of Active Pharmaceutical Ingredients (APIs)…

Addressing Impurity Profile Drift Observed During Stability Studies to Prevent Batch Rejection and Recall The detection of impurity profile drift during stability studies poses a significant risk in pharmaceutical manufacturing,…

Assessing the Regulatory Impact of Impurity Profile Drift Observed in Stability Studies The detection of impurity profile drift during stability studies is a significant concern for pharmaceutical manufacturers and quality…

Investigating Impurity Profile Drift in Pharmaceutical Manufacturing: A Comprehensive Approach Detecting impurity profile drift during a deviation investigation can pose significant challenges for pharmaceutical manufacturers. This scenario raises critical questions…

Impacts of Particle Size Variability on Performance During Regulatory Inspections In the pharmaceutical manufacturing landscape, maintaining consistent quality throughout the production process is essential for regulatory compliance and product efficacy.…

Investigation of API Stability Failures During Stability Studies: Ensuring Compliance with GMP Expectations The pharmaceutical landscape is fraught with challenges around material quality, particularly concerning active pharmaceutical ingredients (API) during…

Framework for Investigating Impurity Profile Drift Detected During Regulatory Inspections Regulatory inspections often reveal critical insights into the quality of Active Pharmaceutical Ingredients (APIs) and their associated excipients. One such…